Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Journal of Translational Medicine|April 17, 2015
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaquesBeatriz Mothe, Xintao Hu, Anuska Llano, et al.
Viruses|September 28, 2021
Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host ResponsesHugo Fernández-Bellon, Jordi Rodon, Leira Fernández-Bastit, et al.
Iscience|March 31, 2023
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralizationEdwards Pradenas, Silvia Marfil, Víctor Urrea, et al.
The Lancet. Microbe|June 10, 2024
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort studyIgor Moraes-Cardoso, Susana Benet, Julieta Carabelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
Scientific Reports|January 14, 2017
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motifLuis M Molinos-Albert, Eneritz Bilbao, Luis Agulló, et al.
Mbio|April 24, 2025
A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 modelAnna Pons-Grífols, Ferran Tarrés-Freixas, Mònica Pérez, et al.
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Life Science Alliance|August 12, 2022
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional studyEugenia Abella, Macedonia Trigueros, Edwards Pradenas, et al.
Age and Ageing|May 20, 2022
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilitiesMacedonia Trigueros, Edwards Pradenas, Dolors Palacín, et al.
Pageof 16